Top

Quality of Life Research

Gepubliceerd in:

24-06-2017

Viability of the World Health Organization quality of life measure to assess changes in quality of life following treatment for alcohol use disorder

Auteurs: Megan Kirouac, Elizabeth R. Stein, Matthew R. Pearson, Katie Witkiewitz

Gepubliceerd in: Quality of Life Research | Uitgave 11/2017

Abstract

Purpose

Quality of life is an outcome often examined in treatment research contexts such as biomedical trials, but has been studied less often in alcohol use disorder (AUD) treatment. The importance of considering QoL in substance use treatment research has recently been voiced, and measures of QoL have been administered in large AUD treatment trials. Yet, the viability of popular QoL measures has never been evaluated in AUD treatment samples. Accordingly, the present manuscript describes a psychometric examination of and prospective changes in the World Health Organization Quality of Life measure (WHOQOL-BREF) in a large sample (N = 1383) of patients with AUD recruited for the COMBINE Study.

Methods

Specifically, we examined the construct validity (via confirmatory factor analyses), measurement invariance across time, internal consistency reliability, convergent validity, and effect sizes of post-treatment changes in the WHOQOL-BREF.

Results

Confirmatory factor analyses of the WHOQOL-BREF provided acceptable fit to the current data and this model was invariant across time. Internal consistency reliability was excellent (α > .9) for the full WHOQOL-BREF for each timepoint; the WHOQOL-BREF had good convergent validity, and medium effect size improvements were found in the full COMBINE sample across time.

Conclusions

These findings suggest that the WHOQOL-BREF is an appropriate measure to use in samples with AUD, that the WHOQOL-BREF scores may be examined over time (e.g., from pre- to post-treatment), and the WHOQOL-BREF may be used to assess improvements in quality of life in AUD research.

vorige artikel Evaluating measurement invariance across assessment modes of phone interview and computer self-administered survey for the PROMIS measures in a population-based cohort of localized prostate cancer survivors

volgende artikel Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)

American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: American Psychiatric Association.CrossRef

Anton, R. F., O’Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., … COMBINE Study Research Group. (2006). Combined pharmacotherapies and behavioral interventions for alcohol dependence: The COMBINE study: A randomized controlled trial. The Journal of the American Medical Association, 295(17), 2003–2017.

Chen, F. F., Sousa, K. H., & West, S. G. (2005). Testing measurement invariance of second-order factor models. Structural Equation Modeling, 12(3), 471–492.CrossRef

Chen, K. H., Wu, C. H., & Yao, G. (2006). Applicability of the WHOQOL-BREF on early adolescence. Social Indicators Research, 79, 215–234. doi:10.1007/s11205-005-0211-0.CrossRef

Cheung, G. W., & Rensvold, R. B. (1999). Evaluating goodness-of-fit indexes for testing measurement invariance. Structural Equation Modeling, 9(3), 233–255.

Cheung, G. W., & Rensvold, R. B. (2002). Evaluating goodness-of-fit indexes for testing measurement invariance. Structural Equation Modeling, 9(2), 233–255. doi:10.1207/S15328007SEM0902_5.CrossRef

Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Earlbaum Associates.

COMBINE Study Group. (2003). Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: Rationale and methods. Alcoholism, Clinical and Experimental Research, 27(7), 1107–1122.CrossRef

10.

Curran, P. J., McGinley, J. S., Baurer, D. J., Hussong, A. M., Burns, A., Chassin, L., ... Zucker, R. (2014). A moderated nonlinear factor model for the development of commensurate measures in integrative data analysis. Multivariate Behavioral Research, 49, 214–231. doi:10.1080/00273171.2014.889594.

11.

Derogatis, L. R. (1993). BSI. Brief Symptom Inventory. Administration, Scoring, and Procedures Manual (3rd ed.) National Computer Systems, Inc., Minneapolis, MN.

12.

Donovan, D. M., Anton, R. F., Miller, W. R., Longabaugh, R., Hosking, J. D., & Youngblood, M. (2008). Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes. Journal of Studies on Alcohol and Drugs, 69, 5–13. doi:10.15288/jsad.2008.69.5.CrossRefPubMed

13.

Donovan, D. M., Bigelow, G. E., Brigham, G. S., Carroll, K. M., Cohen, A. J., Gardin, J. G., … Wells, E. A. (2012). Primary outcome indices in illicit drug dependence treatment research: Systematic approach to selection and measurement of drug use end-points in clinical trials. Addiction, 107(4), 694–708.

14.

Donovan, D., Mattson, M. E., Cisler, R. A., Longabaugh, R., & Zweben, A. (2005). Quality of life as an outcome measure in alcoholism treatment research. Journal of Studies on Alcohol, S15, 119–139.CrossRef

15.

The EuroQol Group. (1990). EuroQol—a new facility for the measurement of health-related quality of life. Health Policy, 16, 199–208.CrossRef

16.

Falk, D., Wan, X. Q., Liu, L., Fertig, J., Mattson, M., Ryan, M., … Litten, R. Z. (2010). Percentage of subjects with no heavy drinking days: Evaluation as an efficacy endpoint for alcohol clinical trials. Alcoholism: Clinical and Experimental Research, 34(12), 2022–2034. doi:10.1111/j.1530-0277.2010.01290.x.

17.

François, C., Rahhali, N., Chalem, Y., Sørensen, P., Luquiens, A., & Aubin, H. J. (2015). The effects of as-needed Nalmefene on patient-reported outcomes and quality of life in relation to a reduction in alcohol consumption in alcohol-dependent patients. PLoS ONE, 10(8), e0129289. doi:10.1371/journal.pone.0129289.CrossRefPubMedPubMedCentral

18.

Gliem, J. A., & Gliem, R. R. (2003). Calculating, interpreting, and reporting Cronbach’s Alpha reliability coefficient for Likert-type scales. In:Midwest Research to Practice Conference in Adult, Continuing, and Community Education, (pp. 82–88). http://www.ssnpstudents.com/wp/wp-content/uploads/2015/02/Gliem-Gliem.pdf.

19.

Hanley, J. A., & McNeil, B. J. (1982). The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology, 143, 29–36.CrossRefPubMed

20.

Hu, L. T., & Bentler, P. M. (1999). Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling, 6, 1–55.CrossRef

21.

IBM Corp. (2015). IBM SPSS Statistics for Windows. Version 23.0. Armonk, NY: IBM Corp.

22.

International Resource Center for Health Care Assessment. (1992). How to score the SF-36 short-form health survey. Boston, MA: The Health Institute.

23.

Jaracz, K., Kalfoss, M., Górna, K., & Bączyk, G. (2006). Quality of life in polish respondents: Psychometric properties of the Polish WHOQOL-BREF. Scandinavian Journal of Caring Science, 20, 251–260.CrossRef

24.

Kaskutas, L. A., Borkman, T. J., Laudet, A., Ritter, L. A., Witdbrodt, J., Subbaraman, M. S., ... Bond, J. (2014). Elements that define recovery: the experiential perspective. Journal of Studies on Alcohol and Drugs, 75, 999–1010. doi:10.15288/jsad.2014.75.999.

25.

Luquiens, A., Reynaud, M., Falissard, B., & Aubin, H. J. (2012). Quality of life among alcohol-dependent patients: How satisfactory are the available instruments? A systematic review. Drug and Alcohol Dependence, 125(3), 192–202. doi:10.1016/j.drugalcdep.2012.08.012.CrossRefPubMed

26.

Lucas-Carrasco, R., Laidlaw, K., & Power, M. J. (2011). Suitability of the WHOQOL-BREF and WHOQOL-OLD for Spanish older adults. Aging Mental Health, 15(5), 595–604. doi:10.1080/13607863.2010.548054.CrossRefPubMed

27.

Marlatt, G. A., & Witkiewitz, K. A. (2010). Harm reduction approaches to alcohol use: Health promotion, prevention, and treatment. Addictive Behaviors, 27(6), 867–886.CrossRef

28.

Midanik, L. T., Greenfield, T. K., & Bond, J. (2007). Addiction sciences and its psychometrics: The measurement of alcohol-related problems. Addiction, 102(11), 1701–1710. doi:10.1111/j.1360-0443.2007.01886.x.CrossRefPubMed

29.

Miller, W. R., Tonigan, J. S., & Longabaugh, R. (1995). The drinker inventory of consequences (DrInC): An instrument for assessing adverse consequences of alcohol abuse. Test manual (Project MATCH Monograph Series, Vol. 4). Rockville, MD: National Institute on Alcohol Abuse and Alcoholism.

30.

Moos, R. H., & Finney, J. W. (1983). The expanding scope of alcoholism treatment evaluation. American Psychologist, 38(10), 1036–1044. doi:10.1037/0003-066X.38.10.1036.CrossRefPubMed

31.

Muthén, L.K., & Muthén, B.O. (2012). Mplus users guide (Version 7).

32.

Neale, J., Finch, E., Marsden, J., Mitcheson, L., Rose, D, Strang, J., … Wykes, T. (2014). How should we measure addiction recovery? Analysis of service provider perspectives using online Delphi groups. Drugs: Education, Prevention and Policy, 21(4), 310–323. doi:10.3109/09687637.2014.918089.

33.

Ohaeri, J. U., Awadalla, A. W., El-Abassi, A. H. M., & Jacob, A. (2007). Confirmatory factor analytical study of the WHOQOL-Bref: Experience with Sudanese general population and psychiatric samples. BMC Medical Research Methodology, 7(1), 37. doi:10.1186/1471-2288-7-37.CrossRefPubMedPubMedCentral

34.

Skevington, S. M., Lofty, M., & O’Connell, K. A. (2004). The World Health Organization’s WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial a report from the WHOQOL Group. Quality of Life Research, 13(2), 299–310.CrossRefPubMed

35.

Skinner, H. A., & Allen, B. A. (1982). Alcohol dependence syndrome: Measurement and validation. Journal of Abnormal Psychology, 91, 199–209.CrossRefPubMed

36.

Tiffany, S. T., Friedman, L., Greenfield, S. F., Hasin, D. S., & Jackson, R. (2012). Beyond drug use: A systematic consideration of other outcomes in evaluations of treatments for substance use disorders. Addiction, 107, 709–718.CrossRefPubMed

37.

Tracy, E. M., Laudet, A., Min, M. O., Kim, H., Brown, S., Jun, M., et al. (2012). Prospective patterns and correlates of quality of life among women in substance abuse treatment. Drug and Alcohol Dependence, 124(3), 242–249. doi:10.1016/j.drugalcdep.2012.01.010.CrossRefPubMedPubMedCentral

38.

Trompenaars, F. J., Masthoff, E. D., Van Heck, G. L., Hodiamont, P. P., & De Vries, J. (2005). Content validity, construct validity, and reliability of the WHOQOL-Bref in a population of Dutch adult psychiatric outpatients. Quality of Life Research, 14(1), 151–160. doi:10.1007/s11136-004-0787-x.CrossRefPubMed

39.

WHOQOL Group. (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological Medicine, 28, 551–558.CrossRef

40.

Widaman K. F., Ferrer E., & Conger R. D. (2010). Factorial invariance within longitudinal structural equation models: measuring the same construct across time. Child Development Perspectives, 4(1), 10–18. doi:10.1111/j.1750-8606.2009.00110.x.

41.

Witkiewitz, K. (2013). “Success” following alcohol treatment: Moving beyond abstinence. Alcoholism, Clinical and Experimental Research, 37(S1), E9–E13. doi:10.1111/acer.12001.CrossRefPubMed

42.

World Health Organization. (2015). International classification of diseases, tenth revision, clinical modification (ICD-10-CM).

43.

Yao, G., & Wu, C. H. (2005). Factorial invariance of the WHOQOL-BREF among disease groups. Quality of Life Research, 14(8), 1881–1888. doi:10.1007/s11136-005-3867-7.CrossRefPubMed

44.

Zubaran, C., & Foresti, K. (2009). Quality of life and substance use: Concepts and recent tendencies. Current Opinion in Psychiatry, 22(3), 281–286. doi:10.1097/YCO.0b013e328328d154.CrossRefPubMed

Titel: Viability of the World Health Organization quality of life measure to assess changes in quality of life following treatment for alcohol use disorder
Auteurs: Megan Kirouac
Elizabeth R. Stein
Matthew R. Pearson
Katie Witkiewitz
Publicatiedatum: 24-06-2017
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 11/2017
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-017-1631-4

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusions

Log in om toegang te krijgen

Andere artikelen Uitgave 11/2017

Resilience to health challenges is related to different ways of thinking: mediators of physical and emotional quality of life in a heterogeneous rare-disease cohort

Longitudinal validity and reliability of the Myeloma Patient Outcome Scale (MyPOS) was established using traditional, generalizability and Rasch psychometric methods

Biopsychosocial factors predict quality of life in thoracolumbar spine surgery

Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)

Psychometric evaluation of an item bank for computerized adaptive testing of the EORTC QLQ-C30 cognitive functioning dimension in cancer patients

Evaluating measurement invariance across assessment modes of phone interview and computer self-administered survey for the PROMIS measures in a population-based cohort of localized prostate cancer survivors